Bigul

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Investor Conference
01-03-2024

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Copy of newspaper publication
28-02-2024

Zydus Lifesciences Ltd - 532321 - Letter Of Offer

Letter of Offer Buyback
27-02-2024

Cadila Pharmaceuticals launches aqueous Vitamin D injection

Cadila Pharmaceuticals' aqueous cholecalciferol injection offers a solution for rapid correction of Vitamin D deficiency
26-02-2024

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus receives WHO prequalification from Miltefosine formulation and API
24-02-2024

Zydus Lifesciences Ltd - 532321 - Incorporation Of A WOS In United Arab Emirates

Incorporation of a WOS in United Arab Emirates
22-02-2024

Zydus Lifesciences Ltd - 532321 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation of loss of share certificate under Reg 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
22-02-2024

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus receives Final Approval from the USFDA for Isosorbide Mononitrate Extended-Release, Tablets USP, 30 mg, 60 mg and 120 mg.
16-02-2024

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Transcript of the Post Results Earnings Call held on February 9, 2024
14-02-2024

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Company is going to participate in an investor conference 'Kotak's Chasing Growth 2024' at Mumbai on Monday, February 19, 2024.
14-02-2024